RemSleep Holdings (RMSL) Cash & Equivalents Growth (1y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | RemSleep Holdings | - | - | -7,636.00 | -53.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -53.70% |
| Sep 30, 2025 | -35.68% |
| Jun 30, 2025 | -40.47% |
| Mar 31, 2025 | -30.57% |
| Dec 31, 2024 | -35.57% |
| Sep 30, 2024 | -40.87% |
| Jun 30, 2024 | -35.44% |
| Mar 31, 2024 | -50.12% |
| Dec 31, 2023 | -60.96% |
| Sep 30, 2023 | -58.15% |
| Jun 30, 2023 | -54.78% |
| Mar 31, 2023 | -63.51% |
| Dec 31, 2022 | -45.56% |
| Sep 30, 2022 | -8.59% |
| Jun 30, 2022 | 582.08% |
| Mar 31, 2022 | 2,426.91% |
| Dec 31, 2021 | 2,862.14% |
| Sep 30, 2021 | 2,341.13% |
| Jun 30, 2021 | 635.01% |
| Mar 31, 2021 | -37.37% |
| Dec 31, 2020 | -4.47% |
| Sep 30, 2020 | -4.77% |
| Jun 30, 2020 | -73.74% |
| Mar 31, 2020 | 471.94% |
| Dec 31, 2019 | 618.59% |
| Sep 30, 2019 | 148.29% |
| Jun 30, 2019 | 32,768.54% |
| Mar 31, 2019 | -15.13% |
| Dec 31, 2018 | 726.22% |
| Sep 30, 2018 | 74,363.64% |
| Mar 31, 2014 | -77.43% |
| Sep 30, 2013 | -100.01% |
| Jun 30, 2013 | -95.82% |
| Mar 31, 2013 | -81.46% |
| Dec 31, 2012 | -92.42% |
| Sep 30, 2012 | -59.11% |